Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	protein phosphatase 4 complex	PPP4R3B PPP4R3A	1.69e-04	6	71	2	GO:0030289
Domain	SMK-1	PPP4R3B PPP4R3A	1.38e-05	2	70	2	PF04802
Domain	DUF625	PPP4R3B PPP4R3A	1.38e-05	2	70	2	IPR006887
Pubmed	A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication.	PPP4R3B IGBP1 PPP4R3A	4.73e-07	8	72	3	18614045
Pubmed	Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.	PPP4R3B PPP4R3A	4.23e-06	2	72	2	16107728
Pubmed	The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair.	TLK2 TLK1	4.23e-06	2	72	2	21647934
Pubmed	PTEN expression contributes to the regulation of muscle protein degradation in diabetes.	PTEN LEPR	4.23e-06	2	72	2	17623817
Pubmed	Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation.	PTEN LEPR	4.23e-06	2	72	2	18054313
Pubmed	Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres.	TLK2 TLK1	4.23e-06	2	72	2	32755577
Pubmed	cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal.	TLK2 TLK1	4.23e-06	2	72	2	9427565
Pubmed	Hepatitis B virus X protein disrupts stress fiber formation and triggers apoptosis.	MYLK3 PTEN	4.23e-06	2	72	2	23591626
Pubmed	Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.	PTEN LEPR	4.23e-06	2	72	2	20852026
Pubmed	Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.	MYC PTEN	4.23e-06	2	72	2	21527520
Pubmed	Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.	MYC PTEN	4.23e-06	2	72	2	21926961
Pubmed	Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.	MYC PTEN	4.23e-06	2	72	2	22281794
Pubmed	Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.	MYC REST	4.23e-06	2	72	2	16478988
Pubmed	Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.	MYC PTEN	4.23e-06	2	72	2	19578399
Pubmed	The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.	MYC PTEN	4.23e-06	2	72	2	14663583
Pubmed	A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity.	PPP4R3B IGBP1 PPP4R3A	6.79e-06	18	72	3	16085932
Pubmed	PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4.	PPP4R3B IGBP1 PPP4R3A	9.46e-06	20	72	3	18715871
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TYK2 ABCC4 TLK1 SHANK2 ANK3 SEPTIN5 ASH1L ARHGEF38 PHF6 QSER1 PTEN VPS13B SEPTIN6	1.04e-05	1489	72	13	28611215
Pubmed	A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.	MYC PTEN	1.27e-05	3	72	2	21685943
Pubmed	Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.	TLK2 TLK1	1.27e-05	3	72	2	28535374
Pubmed	MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.	MYC PTEN	1.27e-05	3	72	2	21394210
Pubmed	MYC deficiency impairs the development of effector/memory T lymphocytes.	MYC PTEN	1.27e-05	3	72	2	34258568
Pubmed	Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.	MYC PTEN	1.27e-05	3	72	2	26554830
Pubmed	Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.	MYC PTEN	1.27e-05	3	72	2	19150964
Pubmed	SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.	MYC PTEN	1.27e-05	3	72	2	22986535
Pubmed	Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects.	PTEN LEPR	1.27e-05	3	72	2	23541372
Pubmed	Suppression of c-Myc is involved in multi-walled carbon nanotubes' down-regulation of ATP-binding cassette transporters in human colon adenocarcinoma cells.	MYC ABCC4	1.27e-05	3	72	2	25461681
Pubmed	Adipose-derived lipocalin 14 alleviates hyperglycaemia by suppressing both adipocyte glycerol efflux and hepatic gluconeogenesis in mice.	OBP2B LEPR	1.27e-05	3	72	2	26592241
Pubmed	Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.	PTEN LEPR	1.27e-05	3	72	2	23963458
Pubmed	MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.	MYC PTEN	1.27e-05	3	72	2	23135913
Pubmed	mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.	MYC PTEN	1.27e-05	3	72	2	27637146
Pubmed	MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN.	MYC PTEN	1.27e-05	3	72	2	28029649
Pubmed	RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.	MYC PTEN	1.27e-05	3	72	2	24444712
Pubmed	c-Myc phosphorylation by PKCζ represses prostate tumorigenesis.	MYC PTEN	1.27e-05	3	72	2	23550155
Pubmed	FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.	PTEN FOXF2	1.27e-05	3	72	2	31858547
Pubmed	MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer.	MYC PTEN	1.27e-05	3	72	2	37704631
Pubmed	Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance.	PTEN LEPR	1.27e-05	3	72	2	31471106
Pubmed	The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression.	TLK2 TLK1	1.27e-05	3	72	2	38498025
Pubmed	C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.	MYC PTEN	1.27e-05	3	72	2	24140063
Pubmed	MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN.	PTEN LEPR	1.27e-05	3	72	2	26996529
Pubmed	Overexpression of microRNA-26a protects against deficient β-cell function via targeting phosphatase with tensin homology in mouse models of type 2 diabetes.	PTEN LEPR	1.27e-05	3	72	2	29191656
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	MYC TLK1 IGBP1 PI4KA ASH1L PTEN	1.60e-05	257	72	6	30945288
Pubmed	Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.	MYC PTEN	2.53e-05	4	72	2	25287161
Pubmed	Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten.	MYC PTEN	2.53e-05	4	72	2	23520049
Pubmed	Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication.	TLK2 TLK1	2.53e-05	4	72	2	10523312
Pubmed	MYC-mediated miR-320a affects receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast formation by regulating phosphatase and tensin homolog (PTEN).	MYC PTEN	2.53e-05	4	72	2	34933640
Pubmed	Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis.	PPP4R3B PPP4R3A	2.53e-05	4	72	2	20876121
Pubmed	Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.	MYC PTEN	2.53e-05	4	72	2	21856866
Pubmed	Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours.	PTEN RFX2	2.53e-05	4	72	2	26690880
Pubmed	The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development.	MYC PTEN	2.53e-05	4	72	2	30524445
Pubmed	Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics.	MYC PTEN	2.53e-05	4	72	2	25937169
Pubmed	Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunity.	MYC PTEN	2.53e-05	4	72	2	38776224
Pubmed	Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1.	PTEN LEPR	2.53e-05	4	72	2	29496446
Pubmed	Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells.	PPP4R3B PPP4R3A	2.53e-05	4	72	2	21423269
Pubmed	Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice.	PTEN LEPR	2.53e-05	4	72	2	21829168
Pubmed	Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases.	TLK2 TLK1	2.53e-05	4	72	2	11470414
Pubmed	TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.	PTEN LEPR	2.53e-05	4	72	2	19543271
Pubmed	Muscle satellite cells are impaired in type 2 diabetic mice by elevated extracellular adenosine.	PTEN LEPR	2.53e-05	4	72	2	35649375
Pubmed	Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2.	COP1 LEPR	2.53e-05	4	72	2	17805301
Pubmed	Modest Declines in Proteome Quality Impair Hematopoietic Stem Cell Self-Renewal.	MYC PTEN	2.53e-05	4	72	2	31914399
Pubmed	Phosphorylation-mediated control of histone chaperone ASF1 levels by Tousled-like kinases.	TLK2 TLK1	2.53e-05	4	72	2	20016786
Pubmed	Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.	MYC PTEN	4.21e-05	5	72	2	27111141
Pubmed	The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas.	MYC TYK2	4.21e-05	5	72	2	21878673
Pubmed	MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.	MYC PTEN	4.21e-05	5	72	2	25829425
Pubmed	A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).	PHF6 PTEN	4.21e-05	5	72	2	21642990
Pubmed	Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation.	SEPTIN5 SEPTIN6	4.21e-05	5	72	2	24113571
Pubmed	β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.	MYC PTEN	4.21e-05	5	72	2	23801632
Pubmed	Tousled-like kinase in a microbial eukaryote regulates spindle assembly and S-phase progression by interacting with Aurora kinase and chromatin assembly factors.	TLK2 TLK1	4.21e-05	5	72	2	17940067
Pubmed	TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.	COP1 LEPR	4.21e-05	5	72	2	16794074
Pubmed	CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.	MYC LEPR	6.31e-05	6	72	2	26058075
Pubmed	Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.	PTEN LEPR	6.31e-05	6	72	2	24953181
Pubmed	HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.	MYC PTEN	6.31e-05	6	72	2	28003334
Pubmed	Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.	TLK2 TLK1	6.31e-05	6	72	2	12660173
Pubmed	Comparative characteristics of genetic aberrations in glioblastomas in children and adults.	MYC PTEN	6.31e-05	6	72	2	25033601
Pubmed	A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.	MYC PTEN	6.31e-05	6	72	2	23908595
Pubmed	Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol.	MYC PTEN	6.31e-05	6	72	2	20729907
Pubmed	Differential localization of septins in the mouse brain.	SEPTIN5 SEPTIN6	8.82e-05	7	72	2	11064363
Pubmed	The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice.	MYC ASH1L	8.82e-05	7	72	2	28374742
Pubmed	FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.	MYC FOXF2	1.17e-04	8	72	2	27425595
Pubmed	Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.	MYC PTEN	1.17e-04	8	72	2	29399633
Pubmed	COP1 is a tumour suppressor that causes degradation of ETS transcription factors.	COP1 PTEN	1.17e-04	8	72	2	21572435
Pubmed	Genetic heterogeneity in colorectal cancer associations between African and European americans.	MYC RHPN2	1.51e-04	9	72	2	20659471
Pubmed	Tethering of an E3 ligase by PCM1 regulates the abundance of centrosomal KIAA0586/Talpid3 and promotes ciliogenesis.	C2CD3 MIB1	1.51e-04	9	72	2	27146717
Pubmed	Smek promotes corticogenesis through regulating Mbd3's stability and Mbd3/NuRD complex recruitment to genes associated with neurogenesis.	PPP4R3B PPP4R3A	1.51e-04	9	72	2	28467410
Pubmed	Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission.	SEPTIN5 SEPTIN6	1.51e-04	9	72	2	18809578
Pubmed	Ku80 binds to human replication origins prior to the assembly of the ORC complex.	MYC ORC3	1.88e-04	10	72	2	15910003
Pubmed	Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.	MYC PTEN	2.30e-04	11	72	2	26063791
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	SHANK2 PTEN	2.30e-04	11	72	2	26403076
Pubmed	Smek1/2 is a nuclear chaperone and cofactor for cleaved Wnt receptor Ryk, regulating cortical neurogenesis.	PPP4R3B PPP4R3A	2.75e-04	12	72	2	29180410
Pubmed	Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells.	MYC TYK2	2.75e-04	12	72	2	12637327
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	PPP4R3B RTL9 MIB1 ASH1L	2.94e-04	153	72	4	10718198
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	SHANK2 PTEN	3.25e-04	13	72	2	27050589
Pubmed	Identification of novel oocyte and granulosa cell markers.	ZFP69 LRRC17	3.25e-04	13	72	2	19539053
Pubmed	β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.	MYC PTEN	3.78e-04	14	72	2	23300485
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	IGBP1 C2CD3 PI4KA PIP4K2A MIB1 QPCT PHF6	3.79e-04	645	72	7	25281560
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TLK2 ANK3 PI4KA ASH1L TMEM254 QSER1 VPS13B SEPTIN6 LRRC17	3.93e-04	1084	72	9	11544199
Pubmed	Localization of septin proteins in the mouse cochlea.	SEPTIN5 SEPTIN6	4.98e-04	16	72	2	22575789
Pubmed	Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.	MYC RHPN2	5.63e-04	17	72	2	24737748
Pubmed	Differential requirements for Tousled-like kinases 1 and 2 in mammalian development.	TLK2 TLK1	5.63e-04	17	72	2	28708136
Pubmed	PTEN Regulates Glucose Transporter Recycling by Impairing SNX27 Retromer Assembly.	IPO4 PTEN	5.63e-04	17	72	2	29117568
Cytoband	19q13.41	ZNF611 ZNF816 ZNF702P	2.59e-04	78	72	3	19q13.41
GeneFamily	Septins	SEPTIN5 SEPTIN6	5.28e-04	13	48	2	732
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	TLK2 MIB1 ASH1L GAN CLSTN2 PTEN	2.21e-05	172	70	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 ANK3 BAIAP2L1 RHPN2 ARHGEF38 CHST9	8.06e-07	200	71	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	CCNJL ABCC4 SHANK2 ANK3 ARHGEF38	6.30e-06	163	71	5	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1 CLSTN2	9.92e-06	179	71	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1 CLSTN2	1.05e-05	181	71	5	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1 CLSTN2	1.10e-05	183	71	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1 CLSTN2	1.13e-05	184	71	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CCNJL SHANK2 ANK3 BAIAP2L1 ARHGEF38	1.16e-05	185	71	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1 CLSTN2	1.26e-05	188	71	5	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNED1 MXRA8 FAXDC2 CLSTN2 LEPR	1.29e-05	189	71	5	d531399749409d614adca13d181830c6e3287508
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNED1 MAB21L3 MXRA8 NDP FOXF2	1.29e-05	189	71	5	3169476f98b7385706cb618c9ad64ae83a290ef0
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	SHANK2 ANK3 BAIAP2L1 ARHGEF38 CHST9	1.32e-05	190	71	5	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SHANK2 ANK3 BAIAP2L1 ARHGEF38 CHST9	1.39e-05	192	71	5	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SNED1 SHANK2 ANK3 CLSTN2 NDP	1.46e-05	194	71	5	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCNJL ABCC4 SHANK2 ANK3 ARHGEF38	1.46e-05	194	71	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	10x3'2.3-week_12-13-Hematopoietic\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYC ABCC4 ART4 FAXDC2 RFESD	1.54e-05	196	71	5	05b437af66cb43ba098ea93a02dc2f7430bf8c1b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SHANK2 ANK3 BAIAP2L1 RHPN2 ARHGEF38	1.58e-05	197	71	5	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 ANK3 ASH1L DEGS2 VPS13B	1.65e-05	199	71	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SNED1 QPCT DEGS2 LEPR FOXF2	1.65e-05	199	71	5	236b1417ed0875e98c6ec1ec714003bfce438d65
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 BAIAP2L1 ARHGEF38 CHST9 DEGS2	1.69e-05	200	71	5	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 ANK3 RHPN2 ARHGEF38 CHST9	1.69e-05	200	71	5	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAB21L3 ARHGEF38 IPO4 F12	4.63e-05	124	71	4	d88bce8a4f023d5b617b2e8e372a94bd1248d20d
ToppCell	PND01-03-samps-Mesenchymal-Pericyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	AMPD1 ADRA1A CLSTN2 LEPR	1.02e-04	152	71	4	fc9472bc19f997103da535b035105f01429cb08e
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYC ADRA1A ART4 MXRA8	1.07e-04	154	71	4	44d4d99b08216c0901e3bc32743fa0a8b85b5149
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	CCNJL ABCC4 ANK3 ARHGEF38	1.16e-04	157	71	4	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAB21L3 SHANK2 ANK3 ARHGEF38	1.30e-04	162	71	4	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYC RHPN2 CHST9 DEGS2	1.37e-04	164	71	4	8d1d0424943d3e98c8b6399dbf702e0035d0db7b
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ARHGEF38 CHST9 DEGS2	1.43e-04	166	71	4	1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ARHGEF38 CHST9 DEGS2	1.43e-04	166	71	4	9628522e7af8f8edca733588a364ab2454ac5ca5
ToppCell	Control\|World / group, cell type (main and fine annotations)	SHANK2 ANK3 BAIAP2L1 RFX2	1.50e-04	168	71	4	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRYBA4 ART4 FAXDC2 RFESD	1.72e-04	174	71	4	001254db9f4c346d06d31a7fa1213498f92e4280
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRYBA4 ART4 FAXDC2 RFESD	1.72e-04	174	71	4	ce2bc1797707c3f48ef551de7edbfd7b47e5a36e
ToppCell	COVID-19-lung-RBC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCC4 ART4 PIP4K2A ZFPM1	1.75e-04	175	71	4	4c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SHANK2 MARK4 FAXDC2 CHST9	1.79e-04	176	71	4	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	COPD-Lymphoid-ILC_A\|COPD / Disease state, Lineage and Cell class	CCNJL PIP4K2A ZNF611 ZFPM1	1.79e-04	176	71	4	484452cb38fe4604f0910a068361ed461b5b0c21
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	CCNJL ABCC4 SHANK2 ARHGEF38	1.79e-04	176	71	4	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	1.79e-04	176	71	4	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHM2 PIP4K2A MARK4 ATL1	1.83e-04	177	71	4	68f1139fc378f351e3b9e9f392aacb150025bf03
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	HINFP ZNF780B MARK4 QSER1	1.87e-04	178	71	4	9a3581a0158dfa5a1cc942f8c532afb5e38b272a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	1.87e-04	178	71	4	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nnat_(Neuron.Slc17a6.Nnat)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MAB21L3 MYLK3 CHST9	1.91e-04	70	71	3	df81f7c1d901eb34b82f564ee15c10a0f4dd153f
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nnat_(Neuron.Slc17a6.Nnat)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MAB21L3 MYLK3 CHST9	1.91e-04	70	71	3	2895c9fa3b2c1fadbcfef7814ee4ce8cc5e76cfd
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ART4 PI4KA MXRA8 ZFP69	1.91e-04	179	71	4	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	LV\|World / Chamber and Cluster_Paper	ADRA1A MYLK3 CHST9 RNF207	1.95e-04	180	71	4	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 ANK3 BAIAP2L1 CLSTN2	1.95e-04	180	71	4	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CCNJL ABCC4 SHANK2 ANK3	1.99e-04	181	71	4	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYC PPP4R3B ANK3 PPP4R3A	2.04e-04	182	71	4	1aea96ee211f7b9caef7fd385233f51be6021a73
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADRA1A ART4 MXRA8 FOXF2	2.04e-04	182	71	4	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADRA1A ART4 MXRA8 FOXF2	2.04e-04	182	71	4	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYC PPP4R3B ANK3 PPP4R3A	2.04e-04	182	71	4	b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYC PPP4R3B ANK3 PPP4R3A	2.04e-04	182	71	4	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYC PPP4R3B ANK3 PPP4R3A	2.04e-04	182	71	4	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	MYC PPP4R3B ANK3 PPP4R3A	2.08e-04	183	71	4	7717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCell	10x5'v1-week_17-19-Hematopoietic-erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYC ART4 FAXDC2 RFESD	2.12e-04	184	71	4	0efc757d9512d6a8fe8176e977a94e4494ed9778
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_progenitors\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SHANK2 ARHGEF38 CHST9 DEGS2	2.12e-04	184	71	4	fcb5dd4fb3fa79f3b6029fad32a474cacde35a3b
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ART4 CLSTN2 PTEN LEPR	2.12e-04	184	71	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	2.17e-04	185	71	4	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	2.17e-04	185	71	4	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1	2.17e-04	185	71	4	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1	2.17e-04	185	71	4	929b68b05b7686341329ac756d7df172cb4b810b
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TYK2 PIP4K2A QPCT SEPTIN6	2.17e-04	185	71	4	ed7b26bdebfd0df2b4f5020a855a052d94ae7219
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CCNJL ABCC4 ANK3 ARHGEF38	2.21e-04	186	71	4	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1	2.21e-04	186	71	4	e83718fabb057100835d3357df407f283d23fe16
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYC MXRA8 CLSTN2 RFX2	2.21e-04	186	71	4	7582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 ART4 MXRA8 CLSTN2	2.26e-04	187	71	4	b6ecf55014f246461bf1ca12f24cb4d046661fa4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 ART4 MXRA8 CLSTN2	2.26e-04	187	71	4	9fb15f24b9b364b0c4704ec98aec236eaec5411c
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	2.26e-04	187	71	4	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma\|TCGA-Prostate / Sample_Type by Project: Shred V9	ABCC4 BAIAP2L1 ARHGEF38 IPO4	2.26e-04	187	71	4	fa0452f3382c22c0391b241d06504fda3c6a19f0
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 ART4 MXRA8 CLSTN2	2.26e-04	187	71	4	e6afbaed352310a1cb49571a2aae18be1f533c9a
ToppCell	TCGA-Prostate-Primary_Tumor\|TCGA-Prostate / Sample_Type by Project: Shred V9	ABCC4 BAIAP2L1 ARHGEF38 IPO4	2.26e-04	187	71	4	3e6a95c912dad5d61e10497ffaafd2b9027cd13a
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANK3 ORC3 MXRA8 ASH1L	2.31e-04	188	71	4	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 SHANK2 ANK3 BAIAP2L1	2.31e-04	188	71	4	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	ADRA1A MYLK3 CHST9 RNF207	2.31e-04	188	71	4	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SHANK2 ANK3 BAIAP2L1 ARHGEF38	2.31e-04	188	71	4	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SHANK2 ANK3 BAIAP2L1 ARHGEF38	2.31e-04	188	71	4	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ADRA1A MYLK3 CHST9 RNF207	2.35e-04	189	71	4	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYC TLK1 ANK3 SEPTIN6	2.35e-04	189	71	4	8130102c41b2978a8b83f765ce383f836a464795
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.35e-04	189	71	4	40cbd679dc0548bf5207e1b033c0597886ad6fe1
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	SHANK2 ANK3 ARHGEF38 CHST9	2.35e-04	189	71	4	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADRA1A ART4 MXRA8 FOXF2	2.35e-04	189	71	4	324c81285c51f4f8bb1aef428b18fe2c549c2c11
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MXRA8 CLSTN2 LEPR FOXF2	2.35e-04	189	71	4	ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADRA1A ART4 MXRA8 FOXF2	2.40e-04	190	71	4	00fd993675faf53adf985b9316a18c8a33242029
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CLSTN2 PTEN LEPR FOXF2	2.40e-04	190	71	4	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADRA1A ART4 MXRA8 FOXF2	2.40e-04	190	71	4	8cda09d761c6b504a744959d587c183f94f1beeb
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CLSTN2 PTEN LEPR FOXF2	2.45e-04	191	71	4	ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SNED1 ART4 CLSTN2 FOXF2	2.45e-04	191	71	4	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	facs-MAT\|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ART4 MXRA8 QPCT LEPR	2.45e-04	191	71	4	b4fba92f9bd1354a07fedfca7304a3757e6d5beb
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 SHANK2 ANK3 ARHGEF38	2.45e-04	191	71	4	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	094c9d3270fc1e487ccf10fb4936af5f081f6009
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	beb5bb42bd53bce01339da9110d374901548793c
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	6609d85fd2577633dcc067507304a6f9e5865ca3
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	CCNJL SHANK2 ANK3 ARHGEF38	2.45e-04	191	71	4	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	c715bbdbbf1482aad45a50a16d5232fd35a9a0bb
ToppCell	facs-Lung-24m-Mesenchymal\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	ba02cbdfda6a94374a6472eb88499059979af472
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	80484d39f34703a33b9bac09826b7a526e883cab
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	243d83cbfcc4996ad087ec6386e559e0b8662004
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	d4f535b06ad483448ab692e9900c872c78cbed60
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	5c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA1A ART4 MXRA8 FOXF2	2.45e-04	191	71	4	b5210de890d338602857b5907135705a507bc2b0
Drug	Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A	CCNJL PLEKHM2 MARK4 FAXDC2 REST VPS13B SEPTIN6	2.14e-06	190	71	7	7154_DN
Drug	2,3,6-trichloroanisole	MIB1 QPCT	9.59e-06	2	71	2	CID000039656
Drug	ms37	TLK2 TLK1	9.59e-06	2	71	2	CID016122503
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYC PPP4R3B TLK1 REST F12 PPP4R3A	1.42e-05	168	71	6	6820_DN
Disease	platelet measurement	ABCC4 SEPTIN5 MARK4 REST F12 ARPC2	9.62e-05	315	69	6	EFO_0005036
Disease	immature platelet measurement	TLK1 SEPTIN5 MARK4 ARPC2	1.78e-04	119	69	4	EFO_0803541
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MYC TYK2 PHF6	2.64e-04	53	69	3	C1961099
Disease	Ductal Carcinoma	MYC PTEN	2.92e-04	11	69	2	C1176475
Disease	renal cell carcinoma (biomarker_via_orthology)	MYC PTEN	4.82e-04	14	69	2	DOID:4450 (biomarker_via_orthology)
Disease	Left ventricular noncompaction	PLEKHM2 MIB1	4.82e-04	14	69	2	C1960469
Disease	Tinnitus, response to cisplatin	ADRA1A PIP4K2A	5.55e-04	15	69	2	GO_0072718, HP_0000360
Disease	calcium measurement	HINFP ABCC4 RTL9 MARK4 QPCT ZFPM1 ATL1	6.59e-04	628	69	7	EFO_0004838
Disease	Fetal Alcohol Syndrome	ANK3 REST	7.16e-04	17	69	2	C0015923
Disease	diastolic blood pressure, systolic blood pressure	PPP4R3B C2CD3 ANK3 OBP2B PIP4K2A PTEN F12	9.62e-04	670	69	7	EFO_0006335, EFO_0006336
Disease	Adenocarcinoma of prostate	MYC PTEN	9.96e-04	20	69	2	C0007112
Disease	Fatty Liver	MYC PTEN LEPR	1.16e-03	88	69	3	C0015695
Disease	Steatohepatitis	MYC PTEN LEPR	1.16e-03	88	69	3	C2711227
Disease	Colorectal Carcinoma	MYC AMPD1 ABCC4 MYLK3 RHPN2 CLSTN2 PTEN	1.26e-03	702	69	7	C0009402
Disease	Adenocarcinoma of large intestine	TYK2 MARK4 PTEN	1.50e-03	96	69	3	C1319315
Disease	Acute kidney injury	SEPTIN5 ATL1	1.56e-03	25	69	2	HP_0001919
Disease	platelet-to-lymphocyte ratio	TYK2 ABCC4 MARK4 ZFPM1 ARPC2	1.62e-03	363	69	5	EFO_0008446
Disease	congestive heart failure (is_implicated_in)	AMPD1 PHF6	1.82e-03	27	69	2	DOID:6000 (is_implicated_in)
Disease	immature platelet count	TLK1 MARK4 ARPC2	1.99e-03	106	69	3	EFO_0803544

Protein segments in the cluster

Peptide	Gene	Start	Entry
ADHCVHYYDLRNTKQ	COP1	576	Q8NHY2
QYHNHSDHYCLNLDS	ASH1L	2191	Q9NR48
VACHRHLHSVTHYYI	ADRA1A	51	P35348
EDIYKIYCYHHDEAH	ARHGEF38	181	Q9NXL2
LHYHIKCSKAYIHTR	ARPC2	251	O15144
YYLLASVSQKDHHCH	CCNJL	201	Q8IV13
HRDFYNCRKVDTHIH	AMPD1	291	P23109
RHHYALYVHNCRLVF	CLSTN2	411	Q9H4D0
AKRHLVLACHYDSKY	QPCT	131	Q16769
HHYKYHVYLICKDEI	QSER1	1676	Q2KHR3
LTFCVEHHTYHIKNY	PPP4R3A	516	Q6IN85
NRYDHYTAHLKHHTR	REST	226	Q13127
SHICLHDYREVYREH	NLRP10	91	Q86W26
SLHKDHYENLYCVVS	JMJD7	176	P0C870
KHHYNVHFNGLECKT	LRRC17	366	Q8N6Y2
REHFINYLTQCHCYH	IGBP1	106	P78318
KRFQYCHSHVLAHAY	OR51G1	166	Q8NGK1
CEGVHYLHQHYILHL	MYLK3	621	Q32MK0
AHKKYYCSSHAAEHV	ZFPM1	991	Q8IX07
DYKDHGYRHCSLAVI	PI4KA	696	P42356
HECHHRYAELYVIDV	LEPR	416	P48357
LTFCVEHHTYHIKNY	PPP4R3B	551	Q5MIZ7
HPLYKDQACYIFHHR	MRPL37	96	Q9BZE1
HKGEYHAMDIRCYHS	RFESD	46	Q8TAC1
HKCVSQHFLKHYFVR	MAB21L3	316	Q8N8X9
YDLCTVCYHGDKHHL	MIB1	106	Q86YT6
VCYHGDKHHLRHRFY	MIB1	111	Q86YT6
LHHLYFYHVQCAGMR	ABCC4	151	O15439
RRDHYIFYCKDQHHG	OBP2B	106	Q9NPH6
HDYHHLKFNQCYGVL	FAXDC2	276	Q96IV6
KLYSAAATHRHLYHQ	ATL1	526	Q8WXF7
LVDKHCGFANHIHYY	BAIAP2L1	196	Q9UHR4
HNHIHKNTYCYLRYK	C2CD3	1426	Q4AC94
ALHYCLHHVHYLATE	GAN	141	Q9H2C0
AASFKKYHVDHHRYL	DEGS2	121	Q6QHC5
DYLTALHVAAHCGHY	ANK3	366	Q12955
QYVLECDHHSGDYKH	CRYBA4	161	P53673
VSAVHYCHQKNIVHR	MARK4	166	Q96L34
DLIRHVYFHCYHTKL	HINFP	81	Q9BQA5
HTHHLAKACYALENF	IPO4	451	Q8TEX9
HNILKKYHQYIVECH	PIP4K2A	156	P48426
HKNHYKIYNLCAERH	PTEN	61	P60484
HVYHMNYFLVLRCLH	ORC3	406	Q9UBD5
HKYYVKNALVCSHDH	PLEKHM2	121	Q8IWE5
SYYHHHHQSVCQDIK	FOXF2	426	Q12947
FQYHRQLYHKCTHKG	F12	51	P00748
QTEEHQHVSKRCYYL	RTL9	1346	Q8NET4
AEHCRHYEDSYRHLQ	RNF207	421	Q6ZRF8
KDVTCDVHYENYRAH	SEPTIN5	296	Q99719
YNHYLRHCQEHKLDP	RFX2	221	P48378
VLKRCHVSTHQHNYA	MYC	296	P01106
CVKAHHYAALAHYFT	RHPN2	346	Q8IUC4
HTYHDSRIHVCLYFI	SEPTIN6	141	Q14141
CHHVYKRVYRVHQDI	SNED1	1371	Q8TER0
CRYGHVQHLEHLLFY	SHANK2	306	Q9UPX8
NYHKHACREYRIHKE	TLK2	506	Q86UE8
AYNISHNAVHYGKHL	CHST9	241	Q7L1S5
TYDHLCKNCHHVIAR	CHURC1	56	Q8WUH1
YHKHACREYRIHKEL	TLK1	501	Q9UKI8
VKTCHRTYHYHCALH	PHF6	96	Q8IWS0
RTYHYHCALHDKAQI	PHF6	101	Q8IWS0
LHLLLECYIQYHHSK	TMEM192	106	Q8IY95
KRYLAYHHRCHTGEK	ZNF702P	46	Q9H963
CVKAHHYTALAHYFT	RHPN2P1	261	A8MT19
YHYQLIEHCRIHTGE	ZNF780B	316	Q9Y6R6
RHHYVDSISHPLYKC	NDP	41	Q00604
HHELYHQISSYPDCK	VPS13B	3291	Q7Z7G8
AFACHSYLAKHTRIH	ZNF611	546	Q8N823
QYLVDHHHTLLCNGY	TMEM254	51	Q8TBM7
YIVYHHRCHTGEKTY	ZNF816	271	Q0VGE8
MAYLHAQHYIHRDLA	TYK2	1011	P29597
CCKTFSHRAYLTHHQ	ZFP69	416	Q49AA0
LCYEVHYRTKDVHFN	ART4	181	Q93070
TCNLHHHYCHLYESL	MXRA8	136	Q9BRK3
HHYCHLYESLAVRLE	MXRA8	141	Q9BRK3